MEG
GMED icon

Millstone Evans Group’s Globus Medical GMED Stock Holding History

Millstone Evans Group’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-80
Closed -$5.86K – 786
2025
Q1 		$5.86K Buy
+80
New +$6.61K ﹤0.01% 582

Other funds holding GMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BAM
Burgundy Asset Management Toronto, Ontario, Canada $10.6B AUM 13.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
HRCM
Hawk Ridge Capital Management Los Angeles, California $2.75B AUM 20.09% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

Millstone Evans Group's GMED Position: Q2 2025 in Review

Millstone Evans Group sold out of Globus Medical (GMED) in Q2 2025, closing a stake of 80 shares — an estimated $5.86K sold.

Millstone Evans Group first reported a position in GMED in Q1 2025 and held it in 1 quarter. The position peaked at $5.86K in Q1 2025. 480 funds tracked by Wall St. Rank hold GMED as of Q2 2025.

  • Millstone Evans Group reported no remaining Globus Medical position as of Q2 2025 after selling out during the quarter.
  • Millstone Evans Group sold 80 Globus Medical shares in Q2 2025, an estimated $5.86K.
  • Millstone Evans Group first reported a position in Globus Medical in Q1 2025 and held it in 1 quarter.
  • Millstone Evans Group's Globus Medical position peaked at $5.86K in Q1 2025.
  • 480 funds tracked by Wall St. Rank held Globus Medical as of Q2 2025.

Based on Millstone Evans Group's 13F filing for Q2 2025, filed 13 Aug 2025.